Optimus Pharma launched a new Anti-Parkinson’s Drug in India
Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in…
![Best and Top Dermatological Care: Celebrating 5 Years of Cozmoderm Clinic’s Journey of Innovation and Excellence](https://thestartupstory.co.in/wp-content/uploads/2024/07/image-1-29.jpg)